Article info
PDFClinical audit
Continuous subcutaneous infusion: is community anticipatory prescribing and administration safe?
- Correspondence to Dr Séamus Coyle, Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK; s.coyle{at}liverpool.ac.uk
Citation
Continuous subcutaneous infusion: is community anticipatory prescribing and administration safe?
Publication history
- Received June 30, 2021
- Accepted November 7, 2021
- First published November 23, 2021.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.